18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

All 0 3 25 28 O
patients 4 12 29 37 O
with 13 17 38 42 O
Surgical 18 26 43 51 B-lower_bound
Stage 27 32 52 57 I-lower_bound
III 33 36 58 61 I-lower_bound
or 37 39 62 64 O
IVA 40 43 65 68 B-upper_bound
endometrial 44 55 69 80 B-cancer
carcinoma 56 65 81 90 I-cancer
per 66 69 91 94 O
FIGO 70 74 95 99 O
2009 75 79 100 104 O
staging 80 87 105 112 O
criteria 88 96 113 121 O
, 96 97 121 122 O
including 98 107 123 132 O
clear 108 113 133 138 O
cell 114 118 139 143 O
and 119 122 144 147 O
serous 123 129 148 154 O
papillary 130 139 155 164 O
and 140 143 165 168 O
undifferentiated 144 160 169 185 O
carcinomas 161 171 186 196 B-cancer

Entry 0 5 197 202 O
into 6 10 203 207 O
the 11 14 208 211 O
study 15 20 212 217 O
is 21 23 218 220 O
limited 24 31 221 228 O
to 32 34 229 231 O
no 35 37 232 234 O
more 38 42 235 239 O
than 43 47 240 244 O
8 48 49 245 246 B-upper_bound
weeks 50 55 247 252 I-upper_bound
from 56 60 253 257 O
the 61 64 258 261 O
date 65 69 262 266 O
of 70 72 267 269 O
surgery 73 80 270 277 B-treatment

Patients 0 8 278 286 O
are 9 12 287 290 O
also 13 17 291 295 O
excluded 18 26 296 304 O
if 27 29 305 307 O
their 30 35 308 313 O
previous 36 44 314 322 B-treatment
cancer 45 51 323 329 I-treatment
treatment 52 61 330 339 I-treatment
contraindicates 62 77 340 355 O
this 78 82 356 360 O
protocol 83 91 361 369 O
therapy 92 99 370 377 B-treatment

Patients 0 8 378 386 O
who 9 12 387 390 O
have 13 17 391 395 O
had 18 21 396 399 O
pelvic 22 28 400 406 B-treatment
or 29 31 407 409 I-treatment
abdominal 32 41 410 419 I-treatment
radiation 42 51 420 429 I-treatment
therapy 52 59 430 437 I-treatment

Patients 0 8 438 446 O
who 9 12 447 450 O
have 13 17 451 455 O
received 18 26 456 464 O
prior 27 32 465 470 B-treatment
chemotherapy 33 45 471 483 I-treatment
for 46 49 484 487 O
endometrial 50 61 488 499 B-cancer
cancer 62 68 500 506 I-cancer

Patients 0 8 507 515 O
with 9 13 516 520 O
FIGO 14 18 521 525 O
2009 19 23 526 530 O
Stage 24 29 531 536 B-cancer
IVB 30 33 537 540 I-cancer
endometrial 34 45 541 552 I-cancer
cancer 46 52 553 559 I-cancer

Patients 0 8 560 568 O
with 9 13 569 573 O
FIGO 14 18 574 578 O
2009 19 23 579 583 O
surgical 24 32 584 592 O
Stage 33 38 593 598 O
I 39 40 599 600 O
or 41 43 601 603 O
II 44 46 604 606 O
endometrial 47 58 607 618 O
clear 59 64 619 624 O
cell 65 69 625 629 O
or 70 72 630 632 O
serous 73 79 633 639 B-cancer
carcinoma 80 89 640 649 I-cancer
and 90 93 650 653 O
with 94 98 654 658 O
positive 99 107 659 667 O
peritoneal 108 118 668 678 O
cytology 119 127 679 687 O

Patients 0 8 688 696 O
with 9 13 697 701 O
a 14 15 702 703 O
GOG 16 19 704 707 B-clinical_variable
Performance 20 31 708 719 I-clinical_variable
Status 32 38 720 726 I-clinical_variable
of 39 41 727 729 O
0 42 43 730 731 B-lower_bound
, 43 44 731 732 O
1 45 46 733 734 O
, 46 47 734 735 O
or 48 50 736 738 O
2 51 52 739 740 B-upper_bound

Patients 0 8 741 749 O
with 9 13 750 754 O
a 14 15 755 756 O
history 16 23 757 764 O
of 24 26 765 767 O
myocardial 27 37 768 778 B-chronic_disease
infarction 38 48 779 789 I-chronic_disease
, 48 49 789 790 O
unstable 50 58 791 799 B-chronic_disease
angina 59 65 800 806 I-chronic_disease
, 65 66 806 807 O
or 67 69 808 810 O
uncontrolled 70 82 811 823 B-chronic_disease
arrhythmia 83 93 824 834 I-chronic_disease
within 94 100 835 841 O
3 101 102 842 843 B-upper_bound
months 103 109 844 850 I-upper_bound
from 110 114 851 855 O
enrollment 115 125 856 866 O

Patients 0 8 867 875 O
with 9 13 876 880 O
a 14 15 881 882 O
history 16 23 883 890 O
of 24 26 891 893 O
other 27 32 894 899 O
invasive 33 41 900 908 B-cancer
malignancies 42 54 909 921 I-cancer

Patients 0 8 922 930 O
with 9 13 931 935 O
a 14 15 936 937 O
history 16 23 938 945 O
of 24 26 946 948 O
serious 27 34 949 956 O
co 35 37 957 959 O
- 37 38 959 960 O
morbid 38 44 960 966 O
illness 45 52 967 974 O
or 53 55 975 977 O
uncontrolled 56 68 978 990 O
illnesses 69 78 991 1000 O
that 79 83 1001 1005 O
would 84 89 1006 1011 O
preclude 90 98 1012 1020 O
protocol 99 107 1021 1029 B-treatment
therapy 108 115 1030 1037 I-treatment

Patients 0 8 1038 1046 O
with 9 13 1047 1051 O
an 14 16 1052 1054 O
estimated 17 26 1055 1064 O
survival 27 35 1065 1073 O
of 36 38 1074 1076 O
less 39 43 1077 1081 O
than 44 48 1082 1086 O
three 49 54 1087 1092 B-upper_bound
months 55 61 1093 1099 I-upper_bound

Patients 0 8 1100 1108 O
with 9 13 1109 1113 O
carcinosarcoma 14 28 1114 1128 B-cancer

Patients 0 8 1129 1137 O
with 9 13 1138 1142 O
parenchymal 14 25 1143 1154 B-cancer
liver 26 31 1155 1160 I-cancer
metastases 32 42 1161 1171 I-cancer

Patients 0 8 1172 1180 O
with 9 13 1181 1185 O
recurrent 14 23 1186 1195 B-cancer
endometrial 24 35 1196 1207 I-cancer
cancer 36 42 1208 1214 I-cancer

Patients 0 8 1215 1223 O
with 9 13 1224 1228 O
residual 14 22 1229 1237 B-cancer
tumor 23 28 1238 1243 I-cancer
after 29 34 1244 1249 O
surgery 35 42 1250 1257 B-treatment
( 43 44 1258 1259 O
any 44 47 1259 1262 O
single 48 54 1263 1269 O
site 55 59 1270 1274 O
) 59 60 1274 1275 O
exceeding 61 70 1276 1285 O
1 71 72 1286 1287 B-lower_bound
cm 73 75 1288 1290 I-lower_bound
in 76 78 1291 1293 I-lower_bound
maximum 79 86 1294 1301 I-lower_bound
dimension 87 96 1302 1311 I-lower_bound

Pelvic 0 6 1312 1318 B-chronic_disease
lymph 7 12 1319 1324 I-chronic_disease
node 13 17 1325 1329 I-chronic_disease
sampling 18 26 1330 1338 O

Surgery 0 7 1339 1346 B-treatment
must 8 12 1347 1351 O
have 13 17 1352 1356 O
included 18 26 1357 1365 O
a 27 28 1366 1367 O
hysterectomy 29 41 1368 1380 B-treatment
and 42 45 1381 1384 O
bilateral 46 55 1385 1394 B-treatment
salpingooophorectomy 56 76 1395 1415 I-treatment

Surgical 0 8 1416 1424 O
Stage 9 14 1425 1430 O
III 15 18 1431 1434 O
disease 19 26 1435 1442 O
includes 27 35 1443 1451 O
those 36 41 1452 1457 O
patients 42 50 1458 1466 O
with 51 55 1467 1471 O
positive 56 64 1472 1480 O
adnexa 65 71 1481 1487 B-chronic_disease
, 71 72 1487 1488 O
parametrial 73 84 1489 1500 B-chronic_disease
involvement 85 96 1501 1512 I-chronic_disease
, 96 97 1512 1513 O
tumor 98 103 1514 1519 B-cancer
invading 104 112 1520 1528 I-cancer
the 113 116 1529 1532 I-cancer
serosa 117 123 1533 1539 I-cancer
, 123 124 1539 1540 O
positive 125 133 1541 1549 O
pelvic 134 140 1550 1556 O
and/or 141 147 1557 1563 O
para 148 152 1564 1568 O
- 152 153 1568 1569 O
aortic 153 159 1569 1575 O
nodes 160 165 1576 1581 O
, 165 166 1581 1582 O
or 167 169 1583 1585 O
vaginal 170 177 1586 1593 O
involvement 178 189 1594 1605 O

Surgical 0 8 1606 1614 B-treatment
Stage 9 14 1615 1620 I-treatment
IVA 15 18 1621 1624 I-treatment
includes 19 27 1625 1633 O
patients 28 36 1634 1642 O
with 37 41 1643 1647 O
bladder 42 49 1648 1655 O
or 50 52 1656 1658 O
bowel 53 58 1659 1664 O
mucosal 59 66 1665 1672 O
involvement 67 78 1673 1684 O
, 78 79 1684 1685 O
but 80 83 1686 1689 O
no 84 86 1690 1692 O
spread 87 93 1693 1699 O
outside 94 101 1700 1707 O
the 102 105 1708 1711 O
pelvis 106 112 1712 1718 O

WBC 0 3 1719 1722 B-clinical_variable
≥ 4 5 1723 1724 O
3000 6 10 1725 1729 B-lower_bound
/ 10 11 1729 1730 I-lower_bound
mcl 11 14 1730 1733 I-lower_bound
Absolute 15 23 1734 1742 B-clinical_variable
neutrophil 24 34 1743 1753 I-clinical_variable
count 35 40 1754 1759 I-clinical_variable
( 41 42 1760 1761 I-clinical_variable
ANC 42 45 1761 1764 I-clinical_variable
) 45 46 1764 1765 I-clinical_variable
≥ 47 48 1766 1767 O
1500 49 53 1768 1772 B-lower_bound
/ 53 54 1772 1773 I-lower_bound
mcl 54 57 1773 1776 I-lower_bound
Platelet 58 66 1777 1785 B-clinical_variable
count 67 72 1786 1791 I-clinical_variable
≥ 73 74 1792 1793 O
100,000 75 82 1794 1801 B-lower_bound
/ 82 83 1801 1802 I-lower_bound
mcl 83 86 1802 1805 I-lower_bound
SGOT 87 91 1806 1810 B-clinical_variable
, 91 92 1810 1811 O
SGPT 93 97 1812 1816 B-clinical_variable
, 97 98 1816 1817 O
and 99 102 1818 1821 O
alkaline 103 111 1822 1830 B-clinical_variable
phosphatase 112 123 1831 1842 I-clinical_variable
≤ 124 125 1843 1844 O
2.5 126 129 1845 1848 B-upper_bound
X 130 131 1849 1850 I-upper_bound
upper 132 137 1851 1856 I-upper_bound
limit 138 143 1857 1862 I-upper_bound
of 144 146 1863 1865 I-upper_bound
normal 147 153 1866 1872 I-upper_bound
( 154 155 1873 1874 I-upper_bound
ULN 155 158 1874 1877 I-upper_bound
) 158 159 1877 1878 I-upper_bound
Bilirubin 160 169 1879 1888 B-clinical_variable
≤ 170 171 1889 1890 O
1.5 172 175 1891 1894 B-upper_bound
X 176 177 1895 1896 I-upper_bound
ULN 178 181 1897 1900 I-upper_bound
Creatinine 182 192 1901 1911 B-clinical_variable
≤ 193 194 1912 1913 O
institutional 195 208 1914 1927 O
ULN 209 212 1928 1931 O

evidence 0 8 1932 1940 O
of 9 11 1941 1943 O
active 12 18 1944 1950 O
malignancy 19 29 1951 1961 B-cancer
within 30 36 1962 1968 O
the 37 40 1969 1972 O
last 41 45 1973 1977 B-upper_bound
five 46 50 1978 1982 I-upper_bound
years 51 56 1983 1988 I-upper_bound

non 0 3 1989 1992 B-cancer
- 3 4 1992 1993 I-cancer
melanoma 4 12 1993 2001 I-cancer
skin 13 17 2002 2006 I-cancer
cancer 18 24 2007 2013 I-cancer

para 0 4 2014 2018 B-chronic_disease
- 4 5 2018 2019 I-chronic_disease
aortic 5 11 2019 2025 I-chronic_disease
lymph 12 17 2026 2031 I-chronic_disease
node 18 22 2032 2036 I-chronic_disease
sampling 23 31 2037 2045 O

